FutureChem Co.,Ltd (KOSDAQ:220100)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,300
+100 (0.43%)
At close: Feb 27, 2026
-6.24%
Market Cap 522.44B
Revenue (ttm) 18.75B
Net Income (ttm) -4.24B
Shares Out 22.42M
EPS (ttm) -191.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 133,975
Average Volume 191,372
Open 23,450
Previous Close 23,200
Day's Range 22,800 - 23,550
52-Week Range 14,900 - 35,050
Beta 0.71
RSI 41.66
Earnings Date Mar 16, 2026

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ... [Read more]

Sector Healthcare
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 220100
Full Company Profile

Financial Performance

In 2024, FutureChem Co.,Ltd's revenue was 17.29 billion, an increase of 23.81% compared to the previous year's 13.97 billion. Losses were -9.42 billion, 40.4% more than in 2023.

Financial Statements

News

There is no news available yet.